Erythrocyte-active agents and treatment of sickle cell disease

被引：15

作者：

Brugnara, C

De Franceschi, L

Beuzard, Y

机构：

[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA

[2] Harvard Univ, Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA

[3] Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy

[4] Hop St Louis, Inst Hematol, Lab Gene Therapy, Paris, France

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 04期

关键词：

D O I：

10.1053/shem.2001.27568

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：324 / 332

页数：9

共 121 条

[1] HOW ALLOSTERIC EFFECTORS CAN BIND TO THE SAME PROTEIN RESIDUE AND PRODUCE OPPOSITE SHIFTS IN THE ALLOSTERIC EQUILIBRIUM [J].

ABRAHAM, DJ ;

SAFO, MK ;

BOYIRI, T ;

DANSODANQUAH, RE ;

KISTER, J ;

POYART, C .

BIOCHEMISTRY, 1995, 34 (46) :15006-15020

[2]

ABRAHAM DJ, 1991, BLOOD, V77, P1334

[3] MODIFICATION OF SICKLE HEMOGLOBIN BY ACETALDEHYDE AND ITS EFFECT ON OXYGENATION, GELATION AND SICKLING [J].

ABRAHAM, EC ;

STALLINGS, M ;

ABRAHAM, A ;

GARBUTT, GJ .

BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 705 (01) :76-81

[4]

ACHARYA AS, 1980, J BIOL CHEM, V255, P1406

[5] RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: A pilot study [J].

AdamsGraves, P ;

Kedar, A ;

Koshy, M ;

Steinberg, M ;

Veith, R ;

Ward, D ;

Crawford, R ;

Edwards, S ;

Bustrack, J ;

Emanuele, M .

BLOOD, 1997, 90 (05) :2041-2046

[6]

ALVAREZ J, 1992, J BIOL CHEM, V267, P11789

[7]

[Anonymous], 1974, JAMA, V228, P1125

[8]

[Anonymous], DISORDERS HEMOGLOBIN

[9]

Armstrong JK, 1997, AM J HEMATOL, V56, P26, DOI 10.1002/(SICI)1096-8652(199709)56:1<26::AID-AJH5>3.3.CO

[10]

2-D

← 1 2 3 4 5 6 7 8 9 10 →